| Field | Specification |
|---|---|
| Applications | |
| Sensitivity | |
| Detection range | |
| Detection method | |
| Assay time | |
| Storage | |
| Shipping | |
| Catalog no. (Mfr.) | |
| Main SKU |
Scientific Background
This ELISA kit applies to the in vitro quantitative determination of AA concentrations in serum, plasma and other biological fluids.
Assay Principle
This ELISA kit uses the Competitive-ELISA principle. The micro ELISA plate provided in this kit has been pre-coated with Universal AA. During the reaction, Universal AA in the sample or standard competes with a fixed amount of Universal AA on the solid phase supporter for sites on the Biotinylated Detection Ab specific to Universal AA. Excess conjugate and unbound sample or standard are washed away, and Avidin-Horseradish Peroxidase (HRP) conjugate are added to each micro plate well and incubated. Then a TMB substrate solution is added to each well. The enzyme-substrate reaction is terminated by the addition of stop solution and the color turns from blue to yellow. The optical density (OD) is measured spectrophotometrically at a wavelength of 450 nm ± 2 nm. The concentration of Universal AA in tested samples can be calculated by comparing the OD of the samples to the standard curve.
Performance Specifications
| Sensitivity | 0.94 ng/mL |
|---|---|
| Detection Range | 1.56-100 ng/mL |
| Total Assay Time | 2 h 30 min |
| Compatible Sample Types | Serum, plasma and other biological fluids |
| Species Reactivity | Universal (multi-species validated) |
| Detection Method | Competitive |
| Precision (CV) | Both intra-CV and inter-CV are < 10%. |
| Recovery Rate | 80%-120% |
| Storage | 2-8℃,12 months |
✓ Research-Grade Validation
Specificity
This kit recognizes Universal AA in samples.No significant cross-reactivity or interference between Universal AA and analogues was observed
Safety & Regulatory
Handle reagents in accordance with institutional biosafety guidelines. Refer to the Safety Data Sheet (SDS) for complete hazard and handling information. Contains components that may require special disposal procedures per local regulations.
This kit is validated for use with Serum, plasma and other biological fluids. For unlisted matrices (e.g., tissue lysate, urine), perform a spike-and-recovery experiment to confirm assay performance before generating reportable data. Sample dilution in the kit's provided diluent is recommended to minimize matrix interference.
The minimum detectable concentration (sensitivity) of this kit is 0.94 ng/mL. Values below this threshold should be reported as below the limit of detection (<LOD) and should not be extrapolated from the standard curve.
The total assay time from sample addition to absorbance reading is approximately 2 h 30 min, including all incubation, wash, and substrate steps. Hands-on time is typically 1–2 hours; most steps involve passive plate incubation. Plan the assay as a single uninterrupted session for best results.
Standard components of this Competitive ELISA Kit typically include: pre-coated microplate (96-well strip format), lyophilized or liquid recombinant AA standard, detection antibody, streptavidin-HRP conjugate, TMB substrate, stop solution, wash buffer concentrate, and sample/standard diluent. Refer to the kit insert or datasheet for the exact component list and storage requirements.
This kit uses colorimetric (TMB/HRP) detection and requires a standard microplate absorbance reader capable of measuring at 450 nm. A reference wavelength of 570 nm or 630 nm is recommended to reduce background. No specialized fluorescence or luminescence reader is needed. Ensure the instrument is calibrated and the plate is clean and free of condensation before reading.
Tissue samples may contain endogenous or exogenous proteases during processing, leading to degradation of extracted proteins. Therefore, it's necessary to add protease inhibitors during processing to ensure the integrity of target proteins. If customers can keep samples cold and handle them quickly during processing, omitting the protease inhibitor may not have a significant effect. After preparation, samples should be tested promptly or immediately aliquoted and frozen at -20°C or -80°C.
What is the range of enzyme activity of your IL-2 freeze-dried powder
What is the principle of adding stop solution to stop color reaction in ELISA experiment?
Can’t Find What You’re Looking For? We can help you source the best match or customize an ELISA solution for your study. Options may include alternative target synonyms, different species reactivity, sample type/matrix compatibility (serum/plasma/lysate/supernatant), assay format (sandwich/competitive), sensitivity/range, detection chemistry (colorimetric/fluorescent/chemiluminescent), plate format (pre-coated/uncoated, strips vs full plate), and bulk or custom packaging. Click Talk to a Scientist to submit a request form, email us at support@biohippo.com, or explore our Research Services for additional support. Our team will be in contact with you shortly.
Leptin-mediated suppression of lipoprotein lipase cleavage enhances lipid uptake and facilitates lymph node metastasis in gastric cancer (2024) Cancer Communications. 10.1002/cac2.12583
Geometric Constraints Regulate Energy Metabolism and Cellular Contractility in Vascular Smooth Muscle Cells by Coordinating Mitochondrial DNA Methylation (2022) Advanced Science. 10.1002/advs.202203995
Targeted Liposomes Sensitize Plastic Melanoma to Ferroptosis via Senescence Induction and Coenzyme Depletion (2024) ACS Nano. 10.1021/acsnano.3c10142
Remodeling adipocytes’ lipid metabolism with a polycation loaded enzyme-active framework reverses osteoporotic bone marrow (2025) Nature Communications. 10.1038/s41467-025-63376-4
MFSD7C protects hemolysis-induced lung impairments by inhibiting ferroptosis (2024) Nature Communications. 10.1038/s41467-024-52537-6
Targeting c-Myc-p300-CARM1 complex induces ferroptosis and reduces CD8+ T cell exhaustion in esophageal squamous cell carcinoma (2026) International Journal of Biological Sciences. 10.7150/ijbs.114575
Plastic poisoning the next generation: omics-anchored partial-adverse outcome pathway affords a glimpse into how gestational polystyrene nano-plastics exposure compromises adult male offspring reproduction (2026) ENVIRONMENT INTERNATIONAL. 10.1016/j.envint.2026.110126
ACAA1 mediates arachidonic acid dysregulation and membrane phospholipid remodeling to promote crystal-cell adhesion and ferroptosis susceptibility in calcium oxalate kidney stone (2025) Journal of Pharmaceutical Analysis. 10.1016/j.jpha.2025.101470
SPINT2 inhibits NEDD4L-mediated ACSL4 ubiquitination to promote ferroptosis and suppress gallbladder cancer progression (2025) INTERNATIONAL JOURNAL OF BIOLOGICAL MACROMOLECULES. 10.1016/j.ijbiomac.2025.148141
Chronic Intermittent Cold Stress-induced lipophagy promotes foamy macrophage susceptibility to ferroptosis and exacerbates atherosclerosis (2025) FREE RADICAL BIOLOGY AND MEDICINE. 10.1016/j.freeradbiomed.2025.11.010
Erigoster B targeting DECR1 induces ferroptosis of breast cancer cells via promoting phosphatidylcholine/arachidonic acid metabolism (2025) npj Precision Oncology. 10.1038/s41698-025-00945-2
Shenqi Fuzheng injection modulates tumor fatty acid metabolism to downregulate MDSCs infiltration, enhancing PD-L1 antibody inhibition of intracranial growth in Melanoma (2023) PHYTOMEDICINE. 10.1016/j.phymed.2023.155171
Embryo-derive TNF promotes decidualization via fibroblast activation (2023) eLife. 10.7554/eLife.82970
Inhibition of the NFATc2/FKBP5 axis alleviates microglial neuroinflammation by regulating arachidonic acid metabolism in Parkinson’s disease (2026) BRAIN BEHAVIOR AND IMMUNITY. 10.1016/j.bbi.2026.106296
Jiawei Xionggui Decoction promotes meningeal lymphatic vessels clearance of β-amyloid by inhibiting arachidonic acid pathway (2024) PHYTOMEDICINE. 10.1016/j.phymed.2024.156041
Fexofenadine Protects Against Intervertebral Disc Degeneration Through TNF Signaling (2021) Frontiers in Cell and Developmental Biology. 10.3389/fcell.2021.687024
Inhibiting arachidonic acid generation mitigates aging-induced hyperinsulinemia and insulin resistance in mice (2024) CLINICAL NUTRITION. 10.1016/j.clnu.2024.05.043
COX-2/PGE2 upregulation contributes to the chromosome 17p-deleted lymphoma (2023) Oncogenesis. 10.1038/s41389-023-00451-9
Systems biology identifies cytosolic PLA2 as a target in vascular calcification treatment (2019) JCI Insight. 10.1172/jci.insight.125638
Blastocyst-Derived Lactic Acid May Regulate S100A6 Expression and Function in Mouse Decidualization via Stimulation of Uterine Epithelial Arachidonic Acid Secretion (2024) Cells. 10.3390/cells13030206
Dapagliflozin Reduces Apoptosis of Diabetic Retina and Human Retinal Microvascular Endothelial Cells Through ERK1/2/cPLA2/AA/ROS Pathway Independent of Hypoglycemic (2022) Frontiers in Pharmacology. 10.3389/fphar.2022.827896
Exploring the “gene–protein–metabolite” network of coronary heart disease with phlegm and blood stasis syndrome by integrated multi-omics strategy (2022) Frontiers in Pharmacology. 10.3389/fphar.2022.1022627
The Arachidonic Acid Metabolism Mechanism Based on UPLC-MS/MS Metabolomics in Recurrent Spontaneous Abortion Rats (2021) Frontiers in Endocrinology. 10.3389/fendo.2021.652807
Lianweng formula alleviates colonic inflammation through gut microbiota-mediated inactivation of the PTGS2/AKR1C3/ALOX5 pathway and subsequent suppression of arachidonic acid metabolism (2026) JOURNAL OF ETHNOPHARMACOLOGY. 10.1016/j.jep.2026.121512
TRIB2 desensitizes ferroptosis via βTrCP-mediated TFRC ubiquitiantion in liver cancer cells (2021) Cell Death Discovery. 10.1038/s41420-021-00574-1
